Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

PG2 Injection 500 mg in Acute Stroke Study (Pass)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2013 by China Medical University Hospital
National Taiwan University Hospital
Shin Kong Wu Ho-Su Memorial Hospital
Tri-Service General Hospital
Changhua Christian Hospital
National Cheng-Kung University Hospital
Kaohsiung Medical University
En Chu Kong Hospital
Kuang Tien General Hospital
Chung Shan Medical University
Taipei Veterans General Hospital, Taiwan
Kaohsiung Veterans General Hospital.
Taipei Medical University Shuang Ho Hospital
Cheng Hsin Rehabilitation Medical Center
Taipei Medical University WanFang Hospital
Information provided by (Responsible Party):
China Medical University Hospital Identifier:
First received: May 20, 2012
Last updated: September 30, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)